Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
TRACK-TBI Longitudinal Biomarker Study
NCT05201833 · View on ClinicalTrials.gov ↗
Study Summary
The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.
Conditions Studied
Interventions
- PROCEDURE Blood Draw
- BEHAVIORAL In-Person Outcome Assessment
- PROCEDURE 3T Magnetic Resonance Imaging (MRI)
- BEHAVIORAL Telephone Outcome Assessment
Study Locations (11)
Texas
- University of Texas at Austin — Austin
- University of Texas Southwestern — Dallas
- Baylor College of Medicine — Houston
Pennsylvania
- University of Pennsylvania/Penn Presbyterian Medical Center — Philadelphia
- University of Pittsburgh — Pittsburgh
California
- University of California, San Francisco — San Francisco
Massachusetts
- Spaulding Rehabilitation Hospital — Charlestown
Ohio
- University of Cincinnati — Cincinnati
Utah
- University of Utah — Salt Lake City
Virginia
- Virginia Commonwealth University — Richmond
Washington
- University of Washington — Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2027-02-28 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05201833
The ClinicalTrials.gov registry entry for NCT05201833 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,457 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 4 interventions — of which Blood Draw is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05201833 reports 11 study locations spanning 8 distinct geographic areas — top geographies include Texas, Pennsylvania, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05201833 about?
NCT05201833 is a clinical study titled "TRACK-TBI Longitudinal Biomarker Study". The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.
What is the current status of trial NCT05201833?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2022-03-01. Estimated completion is 2027-02-28.
What conditions does trial NCT05201833 study?
This clinical trial studies the following conditions: Traumatic Brain Injury. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05201833?
The interventions under investigation include: Blood Draw (PROCEDURE), In-Person Outcome Assessment (BEHAVIORAL), 3T Magnetic Resonance Imaging (MRI) (PROCEDURE), Telephone Outcome Assessment (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05201833?
This trial is sponsored by University of Pennsylvania, which has 1,457 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05201833 being conducted?
This trial has 11 study locations across California, Massachusetts, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.